1. Home
  2. PRQR vs NCV Comparison

PRQR vs NCV Comparison

Compare PRQR & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$2.07

Market Cap

250.7M

Sector

Health Care

ML Signal

HOLD

Logo Virtus Convertible & Income Fund of Beneficial Interest

NCV

Virtus Convertible & Income Fund of Beneficial Interest

HOLD

Current Price

$15.41

Market Cap

350.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRQR
NCV
Founded
2012
2003
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
250.7M
350.4M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
PRQR
NCV
Price
$2.07
$15.41
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$8.14
N/A
AVG Volume (30 Days)
634.1K
405.1K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
12.48%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,859,556.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.07
$2.84
52 Week High
$3.10
$3.59

Technical Indicators

Market Signals
Indicator
PRQR
NCV
Relative Strength Index (RSI) 44.57 53.80
Support Level $2.03 $14.76
Resistance Level $2.31 $15.53
Average True Range (ATR) 0.17 0.18
MACD -0.00 0.04
Stochastic Oscillator 14.29 76.87

Price Performance

Historical Comparison
PRQR
NCV

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About NCV Virtus Convertible & Income Fund of Beneficial Interest

Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.

Share on Social Networks: